Methodological quality and recommendations of hemophilia clinical practice guidelines: A scoping review

Carolina J Delgado-Flores1, David García-Gomero2, Liseth Pinedo-Castillo3,4

  • 1Carrera de Farmacia y Bioquímica, Facultad de Ciencias de la Salud Universidad Científica del Sur Lima Perú.

PubMed

Insights

Quality of hemophilia clinical practice guidelines (CPGs) varies, with inconsistent prophylaxis recommendations. Further development is needed for transparent, evidence-based decision-making in hemophilia care.

Area of Science:

  • Hematology
  • Clinical Practice Guidelines
  • Evidence-Based Medicine

Background:

  • Clinical practice guidelines (CPGs) are crucial for healthcare professionals managing hemophilia.
  • Variations in CPG quality and recommendations necessitate rigorous assessment.
  • This study focuses on hemophilia CPGs published between 2017 and 2021.

Purpose of the Study:

  • To evaluate the methodological quality of hemophilia CPGs.
  • To compare prophylaxis recommendations within these guidelines.
  • To identify areas for improvement in CPG development for hemophilia.

Main Methods:

  • Comprehensive literature search across multiple databases (PubMed, TripDatabase, etc.).
  • Methodological quality assessment using the AGREE-II instrument.
  • Comparative analysis of prophylaxis recommendations, including dose and initiation.

Main Results:

  • Eleven hemophilia CPGs met inclusion criteria; 5 from upper-middle-income countries.
  • Prophylaxis dose recommendations were inconsistent (low, intermediate, or high dose).
  • Few CPGs provided justification for recommendations; no economic evaluations were performed.

Conclusions:

  • Hemophilia CPGs exhibit suboptimal quality and inconsistent prophylaxis recommendations.
  • Lack of justification and transparency hinders evidence-based decision-making.
  • Improvements in CPG development are essential for reliable hemophilia care.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
999
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148